Skip to main content
Clinical Trials/ISRCTN11980212
ISRCTN11980212
Completed
N/A

Assessment of genetic predisposition to development of primary ventricular fibrillation in patients with acute myocardial infarction

niversità degli Studi di Pavia0 sites4,000 target enrollmentDecember 29, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversità degli Studi di Pavia
Enrollment
4000
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 29, 2016
End Date
December 31, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversità degli Studi di Pavia

Eligibility Criteria

Inclusion Criteria

  • 1\. Age between 18 and 75 years, inclusive
  • 2\. At least one episode of cardiac arrest due to ventricular fibrillation within 24 h of onset of symptoms of heart attack documented in the index electrocardiogram
  • 1\. Age between 18 and 75 years, inclusive
  • 2\. Episode of myocardial infarction within 24 h of onset of symptoms

Exclusion Criteria

  • Case Patients
  • 1\. Age younger than 18 or older than 75 years
  • 2\. History of previous myocardial infarction
  • 3\. Pre\-existing significant cardiac disease and / or associated with Ejection Fraction less than or equal to 30%
  • 4\. Presence of arrhythmogenic diseases that affect the occurrence of major ventricular arrhythmias (TV, FV) independently by the ischemic event (arrhythmogenic right end/or left ventricular cardiomiopathies, long\- and short\-QT syndrome; Brugada syndrome and Cathecolaminergic polymorphic ventricular tachicardia)
  • Control Patients
  • 1\. Age younger than 18 or older than 75 years
  • 2\. History of previous myocardial infarction
  • 3\. Pre\-existing significant cardiac disease and / or associated with Ejection Fraction less than or equal to 30%
  • 4\. Presence of arrhythmogenic diseases that affect the occurrence of major ventricular arrhythmias (TV, FV) independently by the ischemic event (arrhythmogenic right end/or left ventricular cardiomiopathies, long\- and short\-QT syndrome; Brugada syndrome and Cathecolaminergic polymorphic ventricular tachicardia)

Outcomes

Primary Outcomes

Not specified

Similar Trials